Latest Infrastructure Investing News

Hastings Technology Metals and JV partner Wyloo have unveiled an updated Definitive Feasibility Study for the Yangibana Rare Earths Project, revealing robust economics and a streamlined path to production with substantial infrastructure already in place.

Cryosite Limited reported an 18% rise in FY2026 revenue to $16.7 million, with EBITDA growing 27% amid completed and ongoing facility expansions. The company aims to convert new capacity into client growth in FY2027.

Gratifii Limited reports FY26 cash receipts slightly exceeding forecasts, driven by early demand for its new enterprise rewards marketplace, Gratifii Connect+, and a live wholesale Travel Platform.

Ioneer has signed non-binding MOUs with Korea’s KIND and Hyundai Engineering, edging closer to a Final Investment Decision for its Rhyolite Ridge lithium-boron project in Nevada.

BCAL Diagnostics has acquired a 10.2% stake in Genetic Signatures for $1.39 million, aiming to merge early cancer detection with infectious disease diagnostics and expand its international footprint.

Lion Rock Minerals (ASX: LRM) has expanded its high-grade rutile footprint at the Minta Project in Cameroon, revealing a 130km² residual rutile corridor with peak rutile grades up to 72.7% heavy mineral and natural rutile nuggets exceeding 98% TiO2 purity.

Beetaloo Energy reports promising flow testing from Carpentaria-5H with sustained gas rates and low decline, while its Carpentaria Gas Plant construction remains on schedule for first gas sales in late 2026.

ikeGPS Group Limited reported a 33% surge in subscription revenue to NZ$19.2 million for FY26, driven by AI-powered product innovation and expanding adoption among North American utilities. The company achieved positive underlying EBITDA in March and ended the year with NZ$33 million cash and no debt.

Ioneer has secured non-binding letters of intent with Korea’s KIND and Hyundai Engineering, marking a key step towards a Final Investment Decision for the Rhyolite Ridge lithium-boron project, targeting first production in 2029.

Symal Group is set to significantly boost its defence and resources contracting presence through the $51 million acquisition of Shamrock Civil, a Queensland-based contractor with a $315 million pipeline dominated by defence projects.

Microba Life Sciences secures $5 million in a placement led by Sonic Healthcare to fund its push towards cashflow break-even by 2027, backed by strong diagnostic sales and AI-driven efficiencies.

PolyNovo has completed its pivotal US clinical trial report for NovoSorb BTM and adjusted its FDA Premarket Approval submission timeline to late 2026 to incorporate updated regulatory requirements and additional data.